Extranodal NK-T-cell lymphoma primary prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Extranodal NK-T-cell lymphom}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the primary prevention of [disease name]. OR There are no ava...") |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Extranodal NK-T-cell | {{Extranodal NK-T-cell lymphoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{RG}} | ||
==Overview== | ==Overview== | ||
There are no established measures for the primary prevention of | There are no established measures for the primary prevention of extranodal NK/T cell lymphoma. | ||
==Primary Prevention== | ==Primary Prevention== | ||
There are no established measures for the primary prevention of | There are no established measures for the primary prevention of extranodal NK/T cell lumphoma.<ref name="Liang2009">{{cite journal|last1=Liang|first1=Raymond|title=Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type|journal=British Journal of Haematology|volume=147|issue=1|year=2009|pages=13–21|issn=00071048|doi=10.1111/j.1365-2141.2009.07802.x}}</ref> | ||
==References== | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 16:15, 2 September 2019
|
Extranodal NK-T-cell lymphoma Microchapters |
|
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extranodal NK-T-cell lymphoma primary prevention On the Web |
|
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma primary prevention |
|
Extranodal NK-T-cell lymphoma primary prevention in the news |
|
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
There are no established measures for the primary prevention of extranodal NK/T cell lymphoma.
Primary Prevention
There are no established measures for the primary prevention of extranodal NK/T cell lumphoma.[1]
References
- ↑ Liang, Raymond (2009). "Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type". British Journal of Haematology. 147 (1): 13–21. doi:10.1111/j.1365-2141.2009.07802.x. ISSN 0007-1048.